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PURPOSE. Mutations in the retinal transcription factor cone-rod homeobox (CRX) gene result in
severe dominant retinopathies. A large animal model, the Rdy cat, carrying a spontaneous
frameshift mutation in Crx, was reported previously. The present study aimed to further
understand pathogenesis in this model by thoroughly characterizing the Rdy retina.
METHODS. Structural and functional changes were found in a comparison between the retinas
of CrxRdy/þ kittens and those of wild-type littermates and were determined at various ages by
fundus examination, electroretinography (ERG), optical coherence tomography, and
histologic analyses. RNA and protein expression changes of Crx and key target genes were
analyzed using quantitative reverse-transcribed PCR, Western blot analysis, and immunohis-
tochemistry. Transcription activity of the mutant Crx was measured by a dual-luciferase
transactivation assay.
RESULTS. CrxRdy/þ kittens had no recordable cone ERGs. Rod responses were delayed in
development and markedly reduced at young ages and lost by 20 weeks. Photoreceptor outer
segment development was incomplete and was followed by progressive outer retinal thinning
starting in the cone-rich area centralis. Expression of cone and rod Crx target genes was
significantly down-regulated. The mutant Crx allele was overexpressed, leading to high levels
of the mutant protein lacking transactivation activity.
CONCLUSIONS. The CrxRdy mutation exerts a dominant negative effect on wild-type Crx by
overexpressing mutant protein. These findings, consistent with those of studies in a mouse
model, support a conserved pathogenic mechanism for CRX frameshift mutations. The
similarities between the feline eye and the human eye with the presence of a central region of
high cone density makes the CrxRdy/þ cat a valuable model for preclinical testing of therapies
for dominant CRX diseases.
Keywords: animal model, cat, CRX, LCA, retinopathy
Inherited retinal degenerations result in a range of differentphenotypes and can be caused by mutations in a multitude of
different genes (currently mutations in 240 different genes that
cause inherited retinal degenerations are listed. RetNet1,
https://sph.uth.edu/retnet; available in the public domain).
Mutations in one of these genes, the cone-rod homeobox (CRX)
gene, cause a spectrum of retinopathies that vary in severity
and age of onset. These CRX-linked retinopathies are mostly
dominantly inherited. Among them, Leber congenital amaurosis
(LCA) is the most severe, leading to vision loss starting in
childhood. The less severe forms have a later onset and can
cause a variety of phenotypes including cone-rod dystrophy,
retinitis pigmentosa, and adult-onset macular dystrophy.2,3 CRX
is an OTX-like homeodomain transcription factor expressed in
both rod and cone photoreceptors and is essential for their
development, maturation, and continued survival.4–7 CRX
interacts with subtype-specific transcription factors to control
rod-versus-cone specification during development and directly
regulates many genes essential for normal retinal function,
including key components of the phototransduction cascade
and the CRX gene itself.8,9 CRX binds to regulatory sequences
of target genes and interacts with cofactors to influence
transcription levels.6,10–13 It has a homeodomain near the N
terminus that mediates DNA binding6,14 and two transactiva-
tion domains in the C-terminal portion for activating target gene
transcription.14
Disease-causing CRX mutations can be grouped into four
classes based on the mutation type and functional characteristic
of the resulting mutant protein.3 Among them, Class III
mutations consist of frameshift and nonsense mutations
causing truncations of the protein affecting the transactivation
domains. The C-terminal truncated forms of CRX maintain DNA
binding but lack transcriptional activation function and thus
have an antimorphic effect.2,3,15,16 All identified Class III
mutations are linked to autosomal dominant LCA or early onset
severe cone-rod dystrophy. To understand the pathogenesis of
the Class III mutations, a knock-in mouse model, Crx-E168d2,
has been generated.15 The 2-bp deletion at the E168 codon
(Glu168del2) is equivalent to a human CRX-LCA mutation.15,17
The heterozygous E168d2 mouse develops severe retinopathy,
similar to that in CRX-LCA, and has been used to complete a
detailed investigation of the disease mechanism.15 This
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investigation revealed that the mutant allele is overexpressed
and interferes with the function of the wild-type (WT) allele.
Although we have learned a great deal from this mouse model,
it has certain limitations. First, the mouse retina differs from
the human retina in photoreceptor distribution, particularly in
the cone mosaic patterns.18–22 Humans have a macula, a
central retinal region of higher photoreceptor density, partic-
ularly of cones, including a central cone-only foveola. This
macula region is responsible for high-acuity color vision. The
lack of an equivalent retinal region in the mouse is especially
problematic for a disease primarily affecting cones at early
stages. Second, it is unclear whether the pathogenic mecha-
nisms learned from this singular animal model are conserved
among mammalian species, including humans.
To overcome the above limitations, we carried out an in-
depth characterization of a feline model, the rod-cone
dysplasia (Rdy) cat, which has a dominantly inherited,
severe retinal dystrophy23–27 due to a 1-bp deletion in Crx
(p.A182d1).28 The frameshift mutation leads to a premature
stop codon at the 185th residue with loss of the last 114
amino acids, eliminating the region of Crx that is presumed
to mediate transactivation. Several human CRX retinopa-
thies, most frequently classified as LCA, are due to frameshift
mutations causing a stop codon at the same position (see
Table 2 in Tran et al.3) (Supplementary Fig. S1).29–38 The Rdy
cat is a valuable model for CRX-LCA because cats have an
area centralis, a region of higher photoreceptor density,
enriched with cones, which has strong similarities to human
macula.39–41 Although the phenotype of the heterozygous
Rdy cat (CrxRdy/þ) has been partially characterized,23–26 the
dynamics of disease progression and underlying molecular
changes have not been investigated. The current study
addresses this knowledge gap by providing a detailed
investigation of the progression of functional, cellular, and
molecular phenotypes of the CrxRdy/þcat. The mutant cat
shows incomplete photoreceptor maturation with cones
more severely affected than rods, followed by a progressive
cone-led photoreceptor degeneration, starting in the cone-
rich area centralis. This phenotype is more accurately
classified at an early onset, severe cone-rod dystrophy
(rather than a rod-cone dystrophy as originally described)
that mimics CRX-LCA. Similar to the E168d2 mouse model,
the CrxRdy/þcat retina undergoes significant biochemical and
molecular changes before and during disease progression.
More strikingly, the mutant Crx allele produces much more
mRNA and protein than the WT allele, supporting across-
species conservation of the cellular and molecular mecha-
nisms underlying Class III CRX mutation-mediated blinding
disease. The CrxRdy/þ cat provides an excellent large animal
model of CRX-LCA and will be invaluable for the preclinical
testing of treatment strategies.
MATERIALS AND METHODS
Ethics Statement
All procedures were performed in accordance with the ARVO
statement for the Use of Animals in Ophthalmic and Vision
Research and approved by the Michigan State University
Institutional Animal Care and Use Committee.
Animals
Purpose-bred CrxRdy cats maintained as a colony at Michigan
State University were used in this study. They were housed
under 12L:12D cycles and fed a commercial feline dry diet
(Purina One Smartblend and Purina kitten chow; Nestle´ Purina,
St. Louis, MO, USA). Animals ranging from 4 weeks to 1 year of
age were studied.
Ophthalmic Examination and Fundus Imaging
Full ophthalmic examinations included indirect ophthalmos-
copy, fundus photography (Ret-Cam II; Clarity Medical
Systems, Inc., Pleasanton, CA, USA), and imaging using
confocal scanning laser ophthalmoscopy (Spectralis OCTþH-
RA; Heidelberg Engineering, Inc., Heidelberg, Germany).
Electroretinography (ERG)
The kittens were dark-adapted for 1 hour, and pupils were
dilated with tropicamide ophthalmic solution, UPS 1% (Falcon
Pharmaceuticals, Ltd., Fort Worth, TX, USA). Anesthesia was
induced and, following intubation, maintained with isoflurane
(IsoFlo; Abbott Laboratories, North Chicago, IL, USA). A Burian-
Allen bipolar electrode contact lens (Burian-Allen ERG
electrode; Hansen Ophthalmic Development Lab, Coralville,
IA, USA) was used, and a platinum needle skin electrode placed
over the occiput was used for grounding (Grass Technologies,
Warwick, RI, USA). ERGs were recorded using an Espion E2
electrophysiology system with ColorDome Ganzfeld (Diag-
nosys LLC, Lowell, MA, USA). A dark-adapted luminance-
response series (4.5 to 1.4 log cd.s/m2), followed by light
adaptation (10 minutes exposure to a 30 cd/m2 white light),
and a light-adapted series (2.4 to 1.4 log cd.s/m2) and 33- Hz
cone flicker (0.4 log cd.s/m2) were recorded. ERG a- and b-
wave amplitudes and implicit times were measured in a
standard fashion.
The leading edge of the rod a-wave was fitted to the Birch
and Hood42 version of the Lamb and Pugh rod photo-
transduction model by using the following equation:
RðI ; tÞ ¼ 1  exp I  S  ðt  tdÞ2
   Rmax for t > td
The amplitude R is a function of the retinal luminance, I, and
time, t, after the flash, and td is a brief delay. S is the sensitivity
factor, and Rmax is the maximum amplitude of the response.
The first limb of the dark-adapted b-wave luminance:ampli-
tude plot was fitted to the Naka-Rushton equation to derive
values for retinal sensitivity (K is semisaturation constant, the
luminance, L, that induces a response amplitude of ½Rmax).
43
R=Rmax ¼ Ln=ðLn þ KnÞ
where Rmax represents the maximum response amplitude of
the first limb of the b-wave luminance:response plot, the K is a
semisaturation constant, considered a measurement of retinal
sensitivity, and n is a factor of the slope of the plot at the
position of K, suggested to indicate retinal homogeneity.
Retinal Morphology
In Vivo Spectral Domain - Optical Coherence Tomog-
raphy (SD-OCT). SD-OCT imaging (Heidelberg Engineering)
was used to capture single-scan line and volume scan images
from the central retina to include the area centralis and from
the four retinal quadrants (4 optic nerve head distances from
the edge of the optic nerve head superiorly, inferiorly, nasally,
and temporally as illustrated in Supplementary Fig. S2).
Thicknesses of the total retinal and outer nuclear layers
(ONL) and receptorþ (including layers between retinal
pigmentary epithelium and outer plexiform layer44) and the
inner retinal layers between the inner nuclear layer and
internal limiting membrane were measured.
Immunohistochemistry (IHC). After cats were eutha-
nized, their eyes were removed and immersed in 4%
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paraformaldehyde (Electron Microscope Sciences, Hatfield,
PA, USA) in phosphate-buffered saline (PBS; Sigma-Aldrich
Corp., St. Louis, MO, USA) on ice for 2 to 3.25 hours. They
were then processed for immunohistochemistry and imaged
as previously described45 (Supplementary Table S1 lists the
antibodies used).
Plastic-Embedded Sections. Eyes were fixed in a 3%
glutaraldehyde, 2% paraformaldehyde solution (Electron Mi-
croscope Sciences) in 0.1 M PBS pH 7.4 (Sigma-Aldrich Corp.)
on ice for 1 hour, then hemisectioned, and the posterior
eyecups were placed in the same fixative overnight. Following
rinsing in 0.1 M sodium cacodylate buffer, samples from the
dorsal, central, and ventral retinal regions were dissected,
embedded in 2% agarose gel, 0.1 M sodium cacodylate buffer,
and then embedded in resin (SPURR; low-viscosity embedding
kit; Electron Microscope Sciences).46 Five hundred-nanometer
sections were stained using epoxy tissue stain (Electron
Microscope Sciences).
Quantitative Reverse Transcriptase-Polymerase
Chain Reaction (qRT-PCR)
Two retinal regions (central and peripheral) from 2-week-old
kittens were dissected (Supplementary Fig. S3A); in older
animals samples were collected from five areas (superior far-
periphery, superior mid-periphery, central [area centralis],
inferior mid-periphery, inferior far-periphery [Supplementary
Fig. S3B]). Samples were flash frozen and stored at808C until
RNA extraction. RNA extraction, cDNA synthesis, and qRT-PCR
reactions were performed as previously described.15 Levels of
arrestin3 (Arr3, specific to cones), rhodopsin (Rho, specific to
rods), and total Crx (WT and mutant) mRNA were measured
and normalized to those of tubulin alpha-1B chain (Tuba1b)
and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; for
primer sequences, see Supplementary Table S2).
Due to the difficulty of establishing a qRT-PCR assay to
differentially amplify mutant and WT Crx cDNA a PCR
restriction enzyme assay was developed to estimate the
mutant-to-WT Crx mRNA ratio. Total combined Crx cDNA
was amplified (forward primer, 5 0-cgtggccacggtgcccatct-3 0
reverse primer 50-tccaggccactgaaatagga-3 0), followed by HpaII
digestion (BioLabs, Inc., Ipswich, MA, USA). The mutant Crx
amplicon (189 bp) is not cut by HpaII, whereas the WT is (112-
and 78-bp products). Following electrophoresis using 2%
agarose gel, the bands were imaged and quantified, and the
mutant amplicon-to-WT amplicon ratio was calculated (Image
Lab version 5.2.1. software; Bio-Rad Laboratories, Hercules, CA,
USA). A control using known WT-to-mutant Crx PCR product
ratios generated from plasmid-cloned WT and mutant feline
Crx was included to verify the accuracy of the technique.
Western Blot Assay
Retina tissue remaining after samples for qRT-PCR were
dissected was flash frozen in liquid nitrogen and stored at
808. Protein extraction from nuclear versus cytoplasmic
fractions and Western blot assay were performed as previously
described.15 Monoclonal mouse anti-b-actin antibody (Sigma-
Aldrich Corp.) and polyclonal rabbit anti-CRX 119b115 at
1:1000 dilution were used to probe the membranes. Secondary
antibodies were goat anti-mouse IRDye 680LT and goat anti-
rabbit IRDye 800CW (LI-COR Biosciences, Lincoln, NE, USA),
respectively. Fluorescence was detected by using an Odyssey
infrared imager (LI-COR Biosciences) and quantified by using
ImageJ software (http://imagej.nih.gov/ij/; provided in the
public domain by the National Institutes of Health, Bethesda,
MD, USA).47
Dual-Luciferase Assay
Dual-luciferase assays were performed as previously de-
scribed.15 HEK293 cells (catalog ATCC CRL-11268; American
Type Culture Collection, Manassas, VA, USA) were cultured in
Dulbecco minimum essential medium (Gibco, Life technolo-
gies, Carlsbad, CA, USA) with 10% fetal bovine serum and
penicillin/streptomycin (100 U/mL; Gibco, Life technologies).
Cells at 60% confluence were transfected with 2 lg of mCrx-
Luc reporter, which carries 500 bp of the mouse Crx
promoter driving firefly luciferase in the pGL3 vector
(Promega Corp., Madison, WI, USA) and 100 ng of pcDNA3.1-
hisc, 100 ng of pCAGIG-feline Crx WT or 100 ng of pCAGIG-
feline CrxRdy, using CaCl2 (0.25 M) and boric acid-buffered
saline (13), pH 6.75, as previously described.15 Cells were
harvested 48 hours post transfection, and dual-luciferase
assays were run.
Statistical Analysis
Statistical analyses of ERG, SD-OCT, cDNA levels, Western
blots, and fluorescence level data differences were tested for
normality (Shapiro-Wilk test for normality). Normally distrib-
uted data were analyzed by using unpaired 2-tailed Student’s t-
tests (significance level set at P < 0.05), nonparametric data by
a Mann-Whitney rank sum U-test (SigmaPlot version 12.0
software; Systat Software, Inc., San Jose, CA, USA).
Statistical analysis of mRNA levels (using qRT-PCR) was
carried out using a 2-way repeat measure ANOVA (Holm-Sidak
parametric method and Shapiro-Wilk normality test) (SigmaPlot
12.0; Systat Software).
RESULTS
CrxRdy/þ Kittens Have Markedly Reduced Retinal
Function
To examine the progression of functional changes in CrxRdy/þ
kittens, ERGs were recorded at multiple time points from 4 to
20 weeks of age (n ¼ 4–8) and compared with those of WT
littermate controls (n¼ 3–7). Light-adapted ERGs could not be
recorded from CrxRdy/þ kittens at any time point. Small dark-
adapted responses were recordable and showed that the
CrxRdy/þ kittens had severely reduced retinal function (Figs. 1,
2). At 4 weeks, a very low amplitude negative waveform typical
of a scotopic threshold response (STR) was recordable from
CrxRdy/þ kittens, whereas the waveform of WT kittens was
similar in shape to that of adult cats (data not shown). By 6
weeks of age the CrxRdy/þ kittens had very small a- and b-wave
responses. Interestingly, responses continued to develop
through 10 weeks of age, although they were very reduced
compared to those in the WT (WT kitten ERGs had peak
amplitudes at 12 weeks of age). After peaking at 10 weeks of
age, responses progressively declined until the ERG was
unrecordable at approximately 20 weeks of age (Figs. 1A,
2C). At peak retinal function (10 weeks of age), the a-wave of
CrxRdy/þ kittens had a threshold similar to that of WT kittens,
although the relatively prominent STR made precise identifi-
cation of the a-wave threshold difficult (Figs. 1A, 2A). However,
compared to the peak WT controls, the peak mean maximum
a-wave amplitude was significantly reduced and delayed, at
only ~30% of the mean control amplitude (P¼0.002) and with
a mean implicit time approximately 2.5 to 4.5 times longer,
depending on the stimulus strength (P < 0.001–0.003) (Figs.
1A, 1B, 2B, 2C). Although the a-wave of the CrxRdy/þ kitten was
very reduced, it was still possible to fit the leading edge of the
response at 10 weeks of age to the Birch-Hood model to assess
rod phototransduction. This showed a significant decrease in
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Rmax in the Crx
Rdy/þ kittens compared to that in WT kittens
(23.86 6 10.34 compared to64.76 6 25.87 lV, respectively;
P ¼ 0.003). The sensitivity log S of the response was also
significantly decreased in the CrxRdy/þ kittens (0.54 6 0.23
compared to 1.27 6 0.12 log td1  s3 (scotopic troland-
seconds) in WT kittens; P < 0.001) (Fig. 1B).
The b-wave of the CrxRdy/þ kitten was even more severely
decreased in amplitude than the a-wave and was also delayed.
At 10 weeks of age, compared to that in WT controls, the b-
wave response threshold was elevated by approximately 1.5 to
2 log units, and the mean maximum amplitude was only ~20%
that of controls (P < 0.001), and implicit times were 2 to 3
FIGURE 1. Dark-adapted luminance series ERG from CrxRdy/þ and WT kittens, a-wave modeling and b-wave Naka-Ruston fitting. (A) Representative
dark-adapted luminance series ERG from CrxRdy/þ and WT kittens at 6, 10, 15, and 20 weeks of age. Flash stimuli ranged from 4.5 (top) to 1.4
(bottom) log cd.s/m2. The CrxRdy/þ kitten has very reduced (note scale differences) and delayed a- and b-waves. Oscillatory potentials were present
on the b-wave of the CrxRdy/þ kitten ERG. Note the relatively large STR in the CrxRdy/þ kitten, which remains prominent to higher flash luminances
than normal; the developing a-wave becoming superimposed on it. A- and b-wave thresholds occurred at similar flash luminances in contrast to
those of the WT, where b-wave threshold occurred at a much lower stimulus strength than the a-wave threshold. (B) Modeling of the leading edge of
the rod-isolated ERG a-wave of a representative CrxRdy/þ and a WT kitten at 10 weeks of age. The raw a-waves (solid lines) and fitted curves (dashed
lines) for four flash stimuli ranging from 0 to 1.4 log cd.s/m2. Note the CrxRdy/þ kitten rod photoreceptor Rmax (maximum receptor response) is
much lower than that of the WT kitten. (C) Naka-Rushton fitting of the first limb of the dark-adapted b-wave luminance:response plot of a
representative CrxRdy/þ and WT kitten at 10 weeks of age. The raw b-wave data values are shown by round symbols and the Naka-Rushton fit by
solid lines. ½Rmax of each waveform is represented by the horizontal dashed lines, and the luminance required to elicit a response of ½Rmax (the
semisaturation constant k) is indicated by the vertical dashed lines. Note the semisaturation constant k of the CrxRdy/þ kitten is elevated by
approximately 0.8 log units compared to that of the WT, and the Rmax (maximum amplitude of the first limb of the b-wave luminance amplitude
plot) is very reduced.
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times longer (P < 0.001–0.071, respectively) (Figs. 1A, 2).
Naka-Rushton fittings were performed in CrxRdy/þ kittens (n¼
7) and WT control kittens (n¼ 6) at 10 weeks of age to derive
values for the Rmax, the semisaturation constant k, and the
slope factor n. All three factors were significantly different
between CrxRdy/þ kittens and WT controls. The mean Rmax was
much lower in CrxRdy/þ kittens (20.1 6 14.7 compared with
169.3 6 52.5 lV in controls; P ¼ 0.001), indicating reduced
retinal function. The mean n factor was increased, suggesting a
reduction in the homogeneity of the retinal response (2.3 6
1.98 compared to 0.91 6 0.08, respectively; P¼0.035). Finally,
the mean luminance required to induce a response of ½Rmax
was significantly increased (0.027 6 0.013 compared to 0.008
6 0.003 cd.s/m2, respectively; P¼0.033), indicating decreased
retinal sensitivity. This ~0.5 log unit increase in stimulus
luminance required to induce a response of ½Rmax was less
than the increase in response threshold for the dark-adapted b-
wave (1.5–2 log units) (Fig. 1C).
CrxRdy/þKittens Have a Progressive Photoreceptor
Degeneration Starting in the Area Centralis
To determine how photoreceptor degeneration evolved in
CrxRdy/þ kittens, in vivo ophthalmic imaging was performed at
FIGURE 2. A-wave and b-wave amplitude and implicit time plotted relative to flash luminance (A, B) and maximal recorded amplitude plotted
relative to age (C). (A) Dark-adapted a- and b-wave luminance-response plots from 10-week-old WT and CrxRdy/þ kittens (the age at which maximum
amplitudes were recordable from the CrxRdy/þ kittens). Note the CrxRdy/þ kittens had markedly reduced a- and b-wave amplitudes. The a-wave
threshold was masked by the STR in the CrxRdy/þ kittens (Fig. 1A). Therefore, the negative component of the waveform at intensities lower than that
indicated by the arrow in the figure consisted of the STR then with increasing intensities a combination of STR and a-wave. At intensities greater
than1.6 log cd.s/m2, the a-wave was clearly discernible. The b-wave threshold was elevated by ~2 log units in CrxRdy/þ kittens. (B) Dark-adapted
STR, a- and b-wave luminance:implicit time plots from 10-week-old WT and CrxRdy/þ kittens. Note the increased implicit times for the CrxRdy/þ
kittens for both a- and b-waves. The implicit times (left plot) at intensities below that indicated by the arrow represent that of the STR. (C) A-wave
and b-wave maximum amplitudes:age plots. The increase in ERG waveforms reflects retinal maturation. Peak amplitudes were recorded at 10 weeks
of age for the CrxRdy/+ kitten compare to 12 weeks of age for WT kittens. By 20 weeks of age the CrxRdy/þ ERG was almost extinguished. †P  0.1; *P
< 0.05; **P < 0.01; and ***P < 0.001 (n ¼ 3 to 8).
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multiple time points from 6 weeks to 1 year of age.
Ophthalmoscopic examinations revealed tapetal hyperreflec-
tivity in CrxRdy/þ kittens (an indication of retinal thinning) in
the area centralis from 7 weeks of age. Generalized tapetal
hyperreflectivity and superficial retinal blood vessel attenua-
tion was apparent from as early as 20 weeks of age (Fig. 3).
Retinal SD-OCT cross-sectional images were recorded from
4 to 26 weeks of age (n¼ 3–8 for CrxRdy/þ kittens and n¼ 2–8
for WT littermate controls). The first abnormality detected in
the CrxRdy/þ kittens was a halt in the maturation of the zone on
the SD-OCT image that corresponded to the photoreceptor
inner and outer segments (IS/OS). This was followed by a
progressive thinning of the outer retinal layers starting in the
area centralis (Fig. 4, Supplementary Fig. S4). The SD-OCT
image of layers representing inner and outer segments was
thinner than in controls, and the bands that comprised the
interdigitation and ellipsoid zones48 could not be discerned in
the CrxRdy/þ kittens. In WT kittens, these zones became clearly
visible as the retina matured (typically they could be seen easily
by 6 weeks of age [Fig. 4A, top]). In the CrxRdy/þ kittens, there
was further progressive thinning of the IS/OS until it
disappeared as the entire outer retina progressively thinned
(Fig. 4A, lower panel). The lamination of the rest of the retina
on SD-OCT imaging initially appeared normal, and at 4 weeks
of age, CrxRdy/þ and WT kittens had comparable ONL
thicknesses in the area centralis (Fig. 4B). Thereafter a
progressive outer retinal thinning occurred starting in the area
centralis and eventually spreading to involve the peripheral
retina (the heat map in Fig. 4C illustrates the more severe
retinal thinning in the area centralis). Despite developing some
retinal function, by 6 weeks of age, the ONL was significantly
thinned in the region of the area centralis (Figs. 4A, 4B), and by
12 weeks of age, it was reduced to ~25% the thickness of that
in the WT kitten (P < 0.001) (Figs. 4A, 4B). The RECþ layer
(which approximates the entire length of the photoreceptors,
i.e., the synaptic termini, cell bodies, and IS/OS) was reduced
by ~50% by 12 weeks of age (P < 0.001) (Figs. 4A, 4B). The
thinning of the outer retinal layers progressed, and by 26
weeks of age, the ONL in the area centralis was no longer
discernible (Figs. 4A, 4B). As the outer retina thinned, the inner
retina initially thickened, such that by 12 weeks the inner
retina of the CrxRdy/þ kittens was ~30% greater than that of
controls in the area centralis region (P < 0.001), whereas due
to the severe thinning of the outer retina, the total retinal
thickness had decreased to ~80% of normal (P < 0.001) (Figs.
4B, 4C). Similar retinal changes developed in the four retinal
quadrants between 10 and 20 weeks of age (Supplementary
Fig. S4).
Examination of plastic-embedded semithin sections revealed
that the maturation of the shape of CrxRdy/þ photoreceptor
nuclei appeared delayed; at 6 weeks of age, they still had a
spindle shape typical of the immature photoreceptor, whereas in
WT kittens, they had gained a mature, round shape by this age
(Fig. 5). Also at this age mislocalized photoreceptor nuclei could
be seen in the subretinal space in the central region of the
CrxRdy/þ kittens (Figs. 5, 6). These mislocalized photoreceptor
nuclei were positive for ML-opsin (medium/long wavelength-
opsin) immunolabeling (Fig. 6). Compared to the well-developed
WT photoreceptor OS, those of CrxRdy/þ kittens were much
shorter and were disorganized. Those defects worsened with
age, and by 20 weeks, OS were no longer apparent (Figs. 5, 6).
To further investigate rod versus cone subcellular structural
changes, immunolabeling of key photoreceptor structural and
phototransduction proteins was performed using frozen retinal
sections (Fig. 6, Supplementary Fig. S5, Supplementary Table
S1). At 2 weeks of age, CrxRdy/þ kittens had minimal human
cone arrestin (hCAR) signals (hCAR labels both cone types)
compared to the WT kittens (Fig. 6). By 6 weeks of age, a
reduced number of hCAR-labeled cones (compared to those in
WT controls) were detectable, but they had very short, stunted
OS as well as shorter IS. At 12 weeks of age, although cones in
the WT retina appeared mature, CrxRdy/þ retinas showed a
severe loss of cones, and the remaining cones had severely
shortened IS/OS. By 20 weeks of age, there were very few
remaining cones. Short wave length cones were more severely
affected than medium and long wave cones. At 2 weeks of age,
S-opsin (short wavelength-opsin) labeling of a few cone cell
bodies and OPL synaptic terminals could be seen in some
animals, but no S-opsin immunolabeling was detected at 6, 12,
and 20 weeks of age (Supplementary Fig. S5). Apart from the
few S-opsin-positive cones at 2 weeks of age, the remaining
cones were ML-opsin-positive (Fig. 6). Occasional stunted ML-
opsin-labeled OS were present, but most labeling was of the
stunted IS, cell bodies, and synaptic terminals, indicative of
mislocalization (in WT controls, ML-opsin only labeled the OS)
(Fig. 6, Supplementary Fig. S5).
CrxRdy/þ retinas had reduced labeling for rod opsin (RetP1,
Fig. 6). Rod OS did start to develop, but this was halted prior to
maturation and was followed by a progressive degeneration
such that by 20 weeks of age they were markedly atrophied in
all retinal regions. Parallel with the failure of rod maturation,
mislocalization of rod opsin to the inner segments, cell body,
and synaptic terminal occurred and was present at all ages
tested.
Immunolabeling for rod bipolar cells (using an anti-
PKCalpha antibody) showed apparently normal numbers of
FIGURE 3. Color fundus views showing progression of fundus changes in CrxRdy/þ kittens from 6 weeks to 1 year of age ([E–H] right eye shown) are
compared to those of WT kittens (A–D). The CrxRdy/þ kitten developed tapetal hyperreflectivity (indicative of retinal thinning) in the area centralis
(high photoreceptor density region [arrows]) as first seen in the image at 12 weeks of age. Hyperreflectivity of the entire tapetal fundus was
discernible from 20 weeks of age and had progressed by 1 year of age. Superficial retinal blood vessel attenuation developed ([H] remaining very
attenuated superficial retinal blood vessels are indicated by arrowheads.
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rod bipolar cells at the ages examined, but their dendrites were
retracted from an early age (Supplementary Fig. S5).
Immunolabeling for glial fibrillary acidic protein (GFAP) was
markedly increased by 12 weeks of age, indicative of extensive
Mu¨ller cell activation (Supplementary Fig. S5).49–51
CrxRdy/þ Retinas Had Markedly Reduced Levels of
Cone and Rod Transcripts
To decipher the molecular changes underlying CrxRdy/þ retinal
pathology, we investigated mRNA levels of selected CRX target
genes, cone arrestin (arrestin3 [Arr3]), rhodopsin (Rho,
specific to rods), and total Crx (mutant plus WT) (Fig. 7,
Supplementary Table S2) in retinal subregions (Supplementary
Fig. S3). For all retinal regions at the four ages tested (2, 6, 12,
and 20 weeks of age), mRNA levels for Arr3 and Rho in the
CrxRdy/þ kittens were significantly decreased. Arr3 was more
dramatically decreased (between 93% and 99%) than Rho
(between 31% and 81%). There were no consistent differences
in the mRNA levels between the different retinal regions
tested. In contrast, Crx mRNA was overexpressed in the
CrxRdy/þ kittens compared to WT controls (between 9% and
185%). For the average of all retinal regions, the difference was
significant at 6 and 20 weeks of age (P ¼ 0.037 and 0.038,
respectively) (Fig. 7A); however, these differences did not
achieve statistical significance for every retinal region tested at
each age. More importantly, when allele-specific expression
levels for the mutant versus WT allele were assessed, a
significantly higher level of mutant Crx transcript than WT
Crx transcript was detected (P < 0.001) (Figs. 7B, 7C), with a
ratio of 7.4 6 0.4 times the amount of mutant transcript in WT
transcript at 6 weeks of age.
This allele-specific overexpression of the mutant product
was confirmed by Western blot assays (Fig. 8). The mutant Crx
protein was at higher levels than the WT Crx protein in the
CrxRdy/þ retinas at each time point (Fig. 8B). The mutant
protein was able to enter the nucleus as indicated by the
results of Western blotting of separated retinal nuclear and
FIGURE 4. Spectral Domain - Optical Coherence Tomography (SD-OCT) in vivo retinal morphology analysis. (A) SD-OCT cross-section views of the
retina in the region of the area centralis of representative WT (1–5) and CrxRdy/þ (6–10) cats at 6, 12, and 20 weeks, 6 months, and 1 year of age. The
white arrows indicate the outer nuclear layer (ONL), which progressively thinned in the area centralis region of CrxRdy/þ cats. Note, specific
features of the SD-OCT image including photoreceptor ellipsoid zone (EZ) and interdigitation zone (IZ) boundaries were not discernible in the
CrxRdy/þ kittens. The magnified image of an OCT image from a WT retina on the right indicates the layers that were measured. TR, total retina; RECþ,
receptor plus, which includes all layers from the interdigitation zone to the outer plexiform layer (OPL), representing the entire photoreceptor cell
length; ONL, outer nuclear layer; IR, inner retina, including all layers from the inner nuclear layer to the external limiting membrane. (B) Thickness
of retinal layers in the area centralis. 1. ONL thickness in area centralis of CrxRdy/þ and WT kittens at 4, 6, 8, 10, 12, 15, and 20 weeks and at 6
months of age. Significant ONL thinning was apparent at 6 weeks of age with a decrease of ~50% normal thickness between 7 and 10 weeks of age
in CrxRdy/þ kittens. By 6 months of age, the ONL was no longer apparent. †P  0.1; ***P < 0.001 (n ¼ 2–8). 2. TR, RECþ, ONL, and IR layer
thicknesses in the area centralis of CrxRdy/þ kittens normalized to those of controls at 4, 6, 8, 10, 12, 15, and 20 weeks and at 6 months of age. ONL,
RECþ, and TR thicknesses were decreased in CrxRdy/þ kittens from 6 weeks of age. In contrast, the IR became significantly thicker in CrxRdy/þ kittens
compared to those in WT kittens. Those differences were statistically significant from 10 weeks of age (P < 0.001 for ONL, RECþ, and TR; P¼0.008
for IR). (C) Total retinal thickness map in the area centralis. The region of the area centralis indicated on the confocal scanning laser
ophthalmoscopy image (1) is represented as a color heat map (the optic nerve head is on the left lower). Warmer colors represent thicker retina,
whereas cooler colors are thinner retina. Although the WT kittens had a relatively homogenous retinal thickness in this region at 6 months of age
(2), the CrxRdy/þ kittens showed progressive thinning in the center of the area centralis, with severe thinning by 6 months of age (3–6). The color
map also demonstrates that, in both WT and CrxRdy/þ kittens, the retina is thicker in the region of retinal vessels and thinner toward the periphery
(top left).
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cytoplasmic fractions (Supplementary Fig. S6). As anticipated
for a heterozygous animal, the amount of WT Crx protein was
lower in the CrxRdy/þ kittens than in WT and the difference was
significant at 12 and 20 weeks of age (P < 0.01) (Fig. 8B).
Because of the overproduction of the truncated mutant
protein, the level of the combined Crx proteins was markedly
higher in the CrxRdy/þ kittens compared to WT kittens at 2, 6,
and 12 weeks of age but not at 20 weeks of age (an age at
which photoreceptor degeneration was well established).
Effect of the Rdy Mutation on Crx’s Transcription
Regulatory Activity
To determine whether the Rdy mutation altered Crx function,
we measured the ability of recombinant Crx proteins to
FIGURE 5. Representative plastic sections of retina from central, dorsal, and ventral regions in WT and CrxRdy/þ kittens at 6 and 20 weeks of age.
Note that mislocalized photoreceptor nuclei ([black arrowheads] see magnified views) were present in the subretinal space or bulging through the
ELM of the central region of the CrxRdy/þ retina at both ages. ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL,
inner plexiform layer; GCL/NFL, ganglion cell layer/nerve fiber layer; white star, photoreceptor IS; black star, photoreceptor OS; black arrow,
external limiting membrane (ELM); white arrowhead, retinal pigmentary epithelium (RPE) nuclei.
FIGURE 6. Immunohistochemistry using rod and cone markers. Frozen sections from the dorsotemporal retinal region of CrxRdy/þ kittens and WT
controls at the indicated ages were immunostained with rhodopsin (RetP1), cone arrestin (hCAR), and medium/long wavelength-opsin (ML-opsin)
along with the pan cone marker peanut agglutinin (PNA). The higher magnification views of CrxRdy/þ sections (bottom row) show mislocalization of
ML-opsin to the inner segments, cell bodies, and pedicles of the cones (white arrowheads). ONL, outer nuclear layer; OPL, outer plexiform layer;
INL, inner nuclear layer; IPL, inner plexiform layer; GCL/ NFL, ganglion cell layer/nerve fiber layer; white arrowhead, mislocalized photoreceptor
nuclei.
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activate the target gene promoter Crx, driving a luciferase
reporter in HEK293 cells. This dual-luciferase reporter assay
revealed that the mutant Crx protein failed to activate the Crx
promoter (P ¼ 0.729), whereas the WT protein led to
significant activation (P < 0.001). (Supplementary Fig. S7),
confirming that this Class III Crx mutation eliminated trans-
activation function.
DISCUSSION
This study expanded on previous studies showing that the
CrxRdy/þ cat has a severe, early onset, dominantly inherited
retinal degeneration.24–27 Similar to other Class III CRX
mutation models, overexpression of the mutant transcript
occurs and most likely exerts a dominant negative effect. These
findings support previous studies in mouse models that suggest
a therapeutic approach by which early intervention to increase
the normal-to-mutant CRX transcript ratios could lessen the
disease severity in CRX-LCA patients.3,15 The CrxRdy/þ cat
enables characterization of the early changes that occur in
retinal regions of high cone density, which model the
environment within the human macula. Such investigations
are not possible in mouse models because mice lack the retinal
regional differences in photoreceptor distribution and density
of the human retina. The cat will be invaluable for preclinical
testing of therapies to rescue photoreceptors in this region that
is so critical for human visual function.
CrxRdy/þ Kitten Provides a Model for Human CRX-
LCA Phenotype
CrxRdy/þ kittens show incomplete maturation of photorecep-
tors associated with reduced expression of photoreceptor
transcripts and followed by progressive photoreceptor degen-
eration. Despite the importance of CRX as a transcription
factor, the retina in the CrxRdy/þ kitten develops relatively
normal stratification (Figs. 4, 5, 6, Supplementary Fig. S5).
Cone nuclei do become aligned to form a single layer in the
outer most row of the ONL, similar to the WT kittens, although
from an early stage, some become mislocalized to the
subretinal space, particularly in the area centralis. In the
p.E168d2 mouse model of Class III CRX mutations, retinal
stratification also develops normally, but in contrast to the cat
model, more extensive mislocalization of cone nuclei to the
inner portions of the ONL occurs.15 The photoreceptor nuclei
in the CrxRdy/þ kittens retain an immature oval shape because
they are delayed in attaining the adult circular appearance in
retinal sections, reflecting incomplete photoreceptor matura-
tion (Figs. 5, 6, Supplementary Fig. S5). Similarly, only partial
development of IS and OS occurs. Cones are more severely
affected than rods, with cone function not being recordable by
ERG at any age and photoreceptor degeneration developing
most rapidly in the area centralis, the region of highest cone
density.39,41 Expression of the cone proteins investigated (cone
arrestin by qRT-PCR and IHC, and cone opsins by IHC) was
much reduced, more so than that of rod opsin (qRT-PCR and
IHC). S-opsin positive cones were only detectable in some
kittens at 2 weeks of age and at no other ages, showing the
most severe effects were on the S-cones. The ML-cones
remained present for longer but only developed very stunted
outer segments which did not show expression of ML-opsin.
The reduced amounts of ML-opsin present were mislocalized
to other parts of the cell (Fig. 6, Supplementary Fig. S5).
Rod photoreceptors showed evidence of maturing further
than cones. Although outer segments were stunted there was
rod opsin present, although expression levels were much
reduced. Rod function was recordable by ERG and showed
evidence of maturation to 10 weeks of age prior to a rapid
decline thereafter (Figs. 1A, 2C). Leon et al.26 had previously
performed a detailed electrophysiological study on the Rdy cat
but needed to use intravitreal recording, or to perform testing
on ex vivo retinal pieces, to reliably record responses and
overcome background electrical noise present when using
corneal electrodes. In the current study it was possible to
record very small ERGs using corneal contact lens electrodes
without resorting to invasive methods. This probably reflects
improvements in recording techniques rather than a drift in
phenotype over the ~25 years since the study by Leon et al.26
Similar to that study, a negative waveform ERG waveform was
recorded to lower stimuli strengths in our study. The shape and
timing of this waveform are in keeping with it representing an
FIGURE 7. Changes of mRNA expression in CrxRdy/þ retinas. (A) qRT-
PCR overall (average of the areas assessed) mRNA expression levels of
arrestin3 (Arr3¼ cone arrestin), rhodopsin (Rho), and Crx in CrxRdy/þ
retina at 2, 6, 12, and 20 weeks of age relative to levels in WT retinas.
The CrxRdy/þ kitten retinas had significantly decreased levels of cone
and rod opsin mRNA. In contrast, the expression of total Crx was
significantly increased. P values comparing the mean CrxRdy/þ and WT
expression levels are †P  0.1, *P < 0.05, **P < 0.01, and ***P < 0.001
(n¼ 3). (B, C) PCR restriction enzyme digest was used to compare the
levels of mutant mRNA to those of WT mRNA by using cDNA from 6-
week-old CrxRdy/þ and WT retinas. (B) Agarose gel of PCR nondigested
(ND) and digested (D) products digested with HpaII, which digests the
amplicon from WT cDNA. Note the presence of both the mutant Crx
transcript (189 bp) and the WT Crx transcript (digested in two
products of 78 and 112 bp) in the CrxRdy/þ kitten retina (kittens 4, 5,
and 6). The WT kitten retina contains only WT Crx transcript
(completely digested in kittens 1, 2, and 3). (C) Wild type-to-mutant
Crx transcript level ratios in WT and CrxRdy/þ kittens. Densitometry
measurements of the bands in the agarose gel ([B] mutant 189 bp and
sum of WT transcript digested products 78 and 112 bp) from the
CrxRdy/þ kitten retinas were assessed. In 6-week-old CrxRdy/þ kitten, the
mutant-to-WT Crx transcript ratio was ~7.4:1 (mutant transcripts
represent 88% of the total transcript; P < 0.001). As expected in WT
kittens, the WT transcript represents 100% of the total Crx mRNA.
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inner retinal component of the ERG present close to response
threshold, the STR.52 A- and b-wave components of the ERG
developed later in age than in WT cats reflecting the delay and
only partial nature of rod photoreceptor maturation. They
were much reduced in amplitude and showed delayed timing.
Modeling of the leading edge of the rod a-wave showed a
significant decrease in maximum amplitude response Rmax and
sensitivity log S (Fig. 1B). This reflects the reduced rod outer
segment length and low rod opsin levels in the affected cats. In
the normal dark-adapted cat ERG the b-wave appears with
increasing strength of stimuli initially superimposed on the STR
and as its amplitude increases obscures it. In the CrxRdy/þ cat
the appearance of the b-wave with increasing stimulus strength
was more severely delayed than that of the a-wave meaning the
a-wave became superimposed on the STR prior to the
development of the b-wave. These findings of a more severe
delay and suppression of the b-wave compared to the a-wave
may reflect an altered maturation of rod bipolar cells which are
the origin of the rod ERG b-wave.53 CRX is expressed in
developing bipolar cells,54 so it is conceivable that impaired
bipolar cell maturation may be a cause for the more severe
changes in the b-wave than the a-wave. An electron microsco-
py study of Rdy cats previously reported an early reduction in
the number of rod spherules and cone pedicles,25 and
synaptophysin (a synaptic vesicle protein) immunolabeling
was reported to be reduced in another study.27 PKCalpha
immunolabeling of rod bipolar cells in this study did not reveal
an alteration in numbers of labeled cells early in the disease
process although an early retraction of dendrites was noted.
Inner retinal components of the ERG such as the STR and
oscillatory potentials which would require bipolar cell signal
transmission were present and relatively prominent in the very
small ERG responses from the CrxRdy/þ kittens.
Naka-Rushton fitting of the rod b-wave luminance:ampli-
tude plots showed very reduced values for the receptor
response and also for retinal sensitivity (Fig. 1C). There was an
increase in the n value, which is a component reflective of the
slope of the plot at the point of ½Rmax and has been suggested
to reflect a less homogeneous retinal response55 and may
reflect the regional variation in the rapidity of photoreceptor
degeneration.
Of the nine reported human disease causing CRX frameshift
mutations that result in a transcript shortened to 185 residues
(as in the CrxRdy cat) (Supplementary Fig. S1), eight were
reported to result in an LCA phenotype.29–38 ERG results were
reported from patients representing seven of the nine
mutations (Supplementary Fig. S1) (see Table 2 in Tran et
al.3). ERGs were not recordable from infants when tested for
three of the mutations.29,34,36,56 When tested in older children
and adults the ERG was also reported to be nonrecord-
able,32,35,37,38 with the exception of one patient reported by
Koenekoop et al.36 who had a p.A177d1 mutation. This patient
FIGURE 8. Western blot analysis for Crx nuclear protein. (A) Western blot analysis of nuclear Crx protein (immunolabeled with antibody 119b1).
The amount of Crx protein present in retinal nuclear extract was investigated by Western blot analysis from kittens at 2, 6, 12, and 20 weeks of age.
Note the presence in the CrxRdy/þ kitten’s retina of the truncated mutant Crx protein, which persisted to the 20-week-old time point, whereas the
amount of WT protein had decreased by 20 weeks of age. Beta-actin was used as protein loading control. (B) Normal and mutant protein levels in
CrxRdy/þ and WT kittens. Crx protein levels were normalized to beta-actin levels, and the CrxRdy/þ kitten protein levels are shown normalized to the
Crx levels in the WT retinas. The level of normal protein was lower in the CrxRdy/þ kitten retina than in WT kittens at each age. Note high levels of
the truncated mutant Crx protein compared to the amount of normal protein in CrxRdy/þ kitten retina and therefore the overall higher total Crx
protein levels (normal plus mutant) in CrxRdy/þ kitten retina compared to WT kitten retina. †P  0.1; *P < 0.05; **P < 0.01 (n¼ 2 to 4; statistical
analysis was applied only when n ‡ 3 for both the WT and the CrxRdy/þ kitten retina sample).
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had a nonrecordable ERG at 8 months of age, then as a child
had some improvement in vision and a recordable cone ERG
when tested at both 10 and 11 years of age. This is the only
instance in the literature where improvement in visual
function was noted in a CRX-LCA patient. It seems likely that
this was due to some degree of delayed retinal maturation
occurring prior to photoreceptor degeneration. Development
of the small ERG responses in the CrxRdy cat are delayed and
there is some evidence of rod maturation but unlike the human
patient, cone function was not recordable and cones
deteriorated prior to rods.
Following the halting of photoreceptor development in the
CrxRdy/þ kitten, a rapid cone-led loss in photoreceptors occurs,
resulting in outer retinal thinning starting in the area centralis
(Fig. 4). With disease progression, outer retinal thinning in the
more peripheral retinal regions also developed (Supplementary
Fig. S4). The initial thickening of the inner retina detected on
SD-OCT imaging, may be due to neuronal remodeling and glial
activation as commonly seen in models of retinal degenera-
tion57 (Supplementary Fig. S5).
Molecular Mechanism Underlying CrxRdy
Phenotype and Implications in Therapy
Development
The CrxRdy mutation results in a premature stop codon in the
transactivation domain of Crx28 the mutant transcript escapes
nonsense-mediated decay and as shown in this study is
overexpressed (Fig. 7). Studies of other Class III CRX mutations
have also shown that there is mutant allele overexpression
(human CRX-LCA p.I138d1 mutation, truncation at codon 185,
and the p.E168d2 knock-in mouse model, truncation at codon
171).15,16,29 The elevation of CrxRdy transcript levels may be
the result of increased synthesis or decreased degradation of
the mutant mRNA. Class III mutation-introduced premature
stop codons could enhance RNA stability of the mutant allele
over its WT counterpart. A feedback regulatory mechanism to
decrease Crx transcripts when overexpressed could attribute
to the reduction of WT Crx transcripts, while mutant allele
transcript is resistant to this regulation. Further studies are
required to ascertain the precise mechanism involved. In the
CrxRdy/þ kitten the mutant transcript and protein remained at
elevated levels even when photoreceptor degeneration was
well established and the levels of expression of the WT allele
were very reduced (Figs. 7, 8). This continued overexpression
of mutant Crx despite photoreceptor loss has not been
previously demonstrated in similar models. Similar to findings
in the p.E168d2 knock-in mouse model, the truncated feline
CrxRdy protein fails to activate its own promoter in vitro
(Supplementary Fig. S7) thus showing across-species conser-
vation of the cellular and molecular mechanisms underlying
Class III CRX mutations.
Prior to loss of photoreceptors potential therapeutic
interventions that address the overexpression of the mutant
Crx transcript may be translatable to human patients. These
include either knocking down the levels of mutant transcript
using, for example, anti-sense oligonucleotides,58–60 or
shRNA,61–63 or overexpressing the WT transcript by gene
supplementation using adeno-associated viral vectors,64–67 or a
combination of both approaches. Supporting evidence for this
approach is provided by a line of E168d2 mice where a Neo
cassette was not excised (E168d2neo) resulting in lowered
expression of the truncated Crx protein and a much milder
phenotype than in the line of E168d2 mice where the Neo
cassette had been excised.15 Also, mice or humans heterozygous
for null mutations in CRX have either a mild phenotype or no
phenotype indicating that severe phenotypes are not the result
of simple haploinsufficiency and supporting the hypothesis of a
dominant negative effect of the mutant protein.5,7
To summarize, the CrxRdy/þ cat provides a large animal
model for the severe dominant CRX mutations associated with
overexpression of a mutant transcript with an antimorphic
effect resulting in a LCA phenotype. The area centralis is
affected earliest and degenerates prior to the peripheral retina.
Presence of the area centralis allows the assessment of
therapeutic interventions aiming to rescue function in this
critical retinal region meaning the CrxRdy cat has a valuable
advantage over mouse models. The slow inner retinal
degeneration in the face of photoreceptor loss and complete
blindness will also make this an excellent model for testing
optogenetic approaches to provide visual function by expres-
sion of light-sensitive proteins in bipolar or ganglion cells.
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